November 2009

Sat, 06/27/2009 - 03:26 By Sabine Vollmer

Research checks

The National Institutes of Health course on "Medicine in the Media" I am attending is a reminder that scientific studies cannot be taken at face value. Somebody needs to double-check the numbers, put them into perspective and expose hidden conflicts of interest researchers may have.

 

Read more...
Tags: NIH, studies, statistics 0 Comments
Thu, 06/25/2009 - 03:24 By Sabine Vollmer

Bad science not sexy enough

Arrived at the National Institutes of Health for the "Medicine in the Media" course just in time to learn that money paid to researchers with a conflict of interest attracts more attention than bad science resulting from their work.

 

Read more...
Tags: UNC, Duke, lung cancer screening, NIH 0 Comments
Tue, 06/23/2009 - 19:33 By Sabine Vollmer

A path to Eureka

It hit me when my mind wandered through a blog post by Robert Lee Hotz, a Wall Street Journal science writer, about research that explores the brain during sudden Eureka moments. Also a contributing factor was a book, that, as I'm reading it, makes me wonder whether it's smarter to be a nematode or a human.

 

What dawned on me was the beginning of an understanding how the Internet can be so ephemeral and yet so powerful.

 

Read more...
Tags: nematode, Internet, evolution, Duke, brain 0 Comments
Fri, 06/19/2009 - 15:54 By Sabine Vollmer

A rising star

Vipin Garg, the chief executive of Tranzyme Pharma, a small Durham drug development company, has the credentials to get invited to official events in the Research Triangle area, such as the opening of Quintiles Transnational's new headquarters last month. But until now, he has shown no appetite for stepping out into the limelight himself.

 

Read more...
Tags: rtp, Tranzyme, innovation, Garg 0 Comments
Fri, 06/12/2009 - 04:07 By Sabine Vollmer

FDA exec hails new drug safety center

I was one of about two dozen visitors Thursday who took a first look at the new Hamner Institute for Drug Safety Sciences. Also among the visitors was Janet Woodcock, a Food and Drug Administration top executive who oversees the approval and regulation of all U.S. medicines. Woodcock called the opening of the 14,000-square-foot research laboratory in Research Triangle Park a "milestone in drug safety regulation."

 

Read more...
Tags: rtp, Hamner, UNC, FDA, drug saferty 0 Comments
Tue, 06/02/2009 - 18:31 By anton

Andrew Witty on science parks

Posted in IASP 2009

In the keynote during the IASP2009 opening, Andrew Witty, chief executive officer of GlaxoSmithKline, started and ended with the thought experiment, "What would North Carolina look like without Research Triangle Park?" Witty lived in Raleigh in the 1990s, and has seen the growth of this region. He said GSK is proud of its innovations arising from its investments in locating to RTP.

Read more...
Tags: intellectual property, innovation, GSK 0 Comments
Tue, 06/02/2009 - 13:30 By anton

Reporting from IASP

Posted in IASP 2009

All today, I'll be attending the International Association of Science Parks XXVI World Conference on Science and Technology Parks at the Raleigh Convention Center. I'm here to capture some of the interesting conversations about the future knowledge ecosystems of the world. Monitor Science in the Triangle and http://twitter.com/mistersugar for my posts and tweets.

 

Read more...
Tags: blogging 0 Comments
Tue, 06/02/2009 - 05:31 By Sabine Vollmer

Patient advocate: FTC opposition to Talecris takeover is "ridiculous"

A treatment for an inherited protein deficiency that causes lung and liver disease features prominently in the Federal Trade Commission's request to block the $3.1 billion takeover of Talecris Biotherapeutics, one of the Research Triangle's largest drugmakers.

 

Read more...
Tags: Talecris, rtp, FTC, CSL 0 Comments
Mon, 06/01/2009 - 16:41 By Sabine Vollmer

Planting seeds and making them grow

Posted in IASP 2009

It's an encouraging historical fact that creativity rises when the economy tanks.

 

That means, the time to plant seeds for tomorrow's innovation is now, when the global economy is shrinking, unemployment is rising and one of the world's largest carmakers, General Moters, is about to restructure in the biggest industrial bankruptcy in U.S. history.

 

Read more...
Tags: rtp, innovation, economic development, Atkinson 0 Comments
Mon, 06/01/2009 - 01:40 By Sabine Vollmer

Mapping RTP's future

Posted in IASP 2009

Science and innovation will continue to drive economic development in the next 20 years, but where the new jobs will spring up is not as clear.

 

The Internet is emphasizing how researchers work over where they work. To solve scientific puzzles increasingly requires more than one researcher, one lab, or one organization. And in the global recession government is trading places with industry in stepping up investment in research and development.

 

Read more...
Tags: Townsend, rtp, Internet, IASP 0 Comments